Company page
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. is a public company traded under the ticker RAPP in the American market. The company has a market capitalization of approximately $1.79 billion. Rapport Therapeutics focuses on developing innovative therapies aimed at addressing unmet medical needs.
- Ticker
- RAPP:NASDAQ
- Asset type
- Stock
- Market cap
- $1.79B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD